A Study to Assess Disease Activity in Adult Participants With Axial Spondyloarthritis Who Receive Upadacitinib in a Real-world Setting
Phase
N/ASpan
241 weeksSponsor
AbbVieBurglengenfeld
Recruiting
21-1 of 1